These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28285296)

  • 21. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
    Jain A; Dixit P; Prasad R
    Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct observation therapy-plus can prevent acquired resistance to fluoroquinolones among patients with multidrug-resistant tuberculosis in Taiwan.
    Chien JY; Lai CC; Tan CK; Yu CJ; Hsueh PR
    Clin Infect Dis; 2013 Apr; 56(7):1054-5. PubMed ID: 23175554
    [No Abstract]   [Full Text] [Related]  

  • 23. High rate of acquired resistance to tuberculosis among HIV-infected subjects of Chennai, South India.
    Vignesh R; Balakrishnan P; Shankar EM; Murugavel KG; Hanas S; Cecelia AJ; Thyagarajan SP; Solomon S; Kumarasamy N; Mayer KH
    J Infect; 2007 Dec; 55(6):e141-2. PubMed ID: 18029020
    [No Abstract]   [Full Text] [Related]  

  • 24. Bedaquiline.
    Goulooze SC; Cohen AF; Rissmann R
    Br J Clin Pharmacol; 2015 Aug; 80(2):182-4. PubMed ID: 25702772
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.
    Ahmad N; Khan AH; Syed Sulaiman SA; Javaid A
    Int J Mycobacteriol; 2015 Sep; 4(3):258-9. PubMed ID: 27649876
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention.
    Almeida D; Rodrigues C; Udwadia ZF; Lalvani A; Gothi GD; Mehta P; Mehta A
    Clin Infect Dis; 2003 Jun; 36(12):e152-4. PubMed ID: 12802779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 28. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 29. Programmatic management of multidrug-resistant tuberculosis--15 years later.
    Nardell EA
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1280. PubMed ID: 22283883
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].
    Alberte-Castiñeiras A; Campos-Bueno A; López-Urrutia L; Alvarez-Alonso E; Megías G; Ojeda-Fernández E; López-Medrano R; Iglesias-García J; García-Carbajosa S; Pérez-Pascual P
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):706-9. PubMed ID: 20627375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.
    Prasad R; Gupta N; Banka A
    Indian J Med Res; 2017 Sep; 146(3):301-303. PubMed ID: 29355135
    [No Abstract]   [Full Text] [Related]  

  • 33. [Multidrug-resistant tuberculosis: current epidemiology, therapeutic regimens, new drugs].
    Gómez-Ayerbe C; Vivancos MJ; Moreno S
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():35-8. PubMed ID: 27608311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-drug resistant tuberculous meningitis.
    Kambli P; Nikam C; Shetty A; Soman R; Rodrigues C
    Indian J Med Microbiol; 2016; 34(2):255. PubMed ID: 27080792
    [No Abstract]   [Full Text] [Related]  

  • 35. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Alffenaar JW; Caminero JA; Abdo Arbex M; Alarcon Guizado V; Aleksa A; Dore S; Gaga M; Gualano G; Kunst H; Payen MC; Roby Arias AJ; Skrahina A; Solovic I; Sulis G; Tadolini M; Zumla A; Migliori GB;
    Eur Respir J; 2016 Nov; 48(5):1503-1507. PubMed ID: 27587544
    [No Abstract]   [Full Text] [Related]  

  • 37. [Joint Statement on the New WHO Recommendations for Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis].
    Maurer FP; Bauer T; Diel R; Häcker B; Lange C; Niemann S; Otto-Knapp R; Schönfeld N
    Pneumologie; 2019 May; 73(5):270-273. PubMed ID: 31083750
    [No Abstract]   [Full Text] [Related]  

  • 38. Extensive drug-resistant TB: a threat for Europe?
    Manissero D; Fernandez de la Hoz K
    Euro Surveill; 2006 Sep; 11(9):E060928.2. PubMed ID: 17075155
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-resistant tuberculosis in Zhejiang Province, China, 1999-2008.
    Wang X; Fu Q; Li Z; Chen S; Liu Z; Nelson H; Yang Q; Jia Z; Dye C
    Emerg Infect Dis; 2012 Mar; 18(3):496-8. PubMed ID: 22377167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Multidrug-resistant Tuberculosis Infection in Children.
    Cruz AT; Garcia-Prats AJ; Furin J; Seddon JA
    Pediatr Infect Dis J; 2018 Aug; 37(8):831-834. PubMed ID: 29742640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.